HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Increased CD40 expression on articular chondrocytes from patients with rheumatoid arthritis: contribution to production of cytokines and matrix metalloproteinases.

AbstractOBJECTIVE: To examine expression of CD40 on articular chondrocytes derived from patients with rheumatoid arthritis (RA) and osteoarthritis (OA) and to investigate roles of CD40 on articular chondrocytes in production of inflammatory mediators associated with degradation of articular cartilage. METHODS: Articular cartilage samples were obtained from patients with RA and OA at total knee arthroplasty. Expression of CD40 on chondrocytes was examined using immunohistochemistry, reverse transcriptase-polymerase chain reaction (RT-PCR), and flow cytometry. Tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (IL-6), matrix metalloproteinase (MMP)-3, and tissue inhibitor of matrix metalloproteinase (TIMP)-1 in culture supernatants of chondrocytes were measured by ELISA. RESULTS: Immunohistochemical staining revealed that CD40 was expressed on RA chondrocytes in vivo, but not in OA chondrocytes. RT-PCR and flow cytometry showed that cultured articular chondrocytes from RA patients, but not from OA patients, constitutively expressed CD40, and that interferon-gamma (IFN-gamma) enhanced the expression of CD40 on chondrocytes from both RA and OA patients. Membrane fraction of mouse myeloma Ag8 cells that was transfected with human CD154 (Ag8-hCD154) induced production of TNF-alpha, IL-6, and MMP-3 in RA chondrocytes, and pretreatment of RA chondrocytes with IFN-gamma enhanced the response. OA chondrocytes did not respond to stimulation with the membrane fraction of Ag8-hCD154 cells alone, but the cells did produce TNF-alpha, IL-6, and MMP-3 after pretreatment with IFN-gamma. CONCLUSION: CD40-CD154 interaction augments the expression of inflammatory cytokines and MMP in chondrocytes and contributes to an intrinsic process of cartilage degradation in RA.
AuthorsHaruhiko Gotoh, Yasushi Kawaguchi, Masayoshi Harigai, Masako Hara, Seiji Saito, Toshihito Yamaguchi, Katsuhiro Shimada, Manabu Kawamoto, Taisuke Tomatsu, Naoyuki Kamatani (Affiliation: Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan.)
JournalThe Journal of rheumatology (J Rheumatol) Vol. 31 Issue 8 Pg. 1506-12 (Aug 2004) ISSN: 0315-162X [Print] Canada
PMID15290728 (Publication Type: Journal Article)
Chemical References
  • Antigens, CD40
  • Cytokines
  • Interleukin-6
  • RNA, Messenger
  • Tissue Inhibitor of Metalloproteinase-1
  • Tumor Necrosis Factor-alpha
  • CD40 Ligand
  • Interferon-gamma
  • Matrix Metalloproteinase 3
Topics
  • Animals
  • Antigens, CD40 (genetics, metabolism)
  • Arthritis, Rheumatoid (metabolism, pathology)
  • CD40 Ligand (metabolism)
  • Cartilage, Articular (metabolism, pathology)
  • Cell Line, Tumor
  • Cells, Cultured
  • Chondrocytes (drug effects, metabolism)
  • Cytokines (metabolism)
  • Flow Cytometry
  • Frozen Sections
  • Humans
  • Immunohistochemistry (methods)
  • Interferon-gamma (pharmacology)
  • Interleukin-6 (metabolism)
  • Matrix Metalloproteinase 3 (metabolism)
  • Mice
  • Osteoarthritis (metabolism, pathology)
  • RNA, Messenger (metabolism)
  • Staining and Labeling
  • Tissue Inhibitor of Metalloproteinase-1 (metabolism)
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD